Psilocybin, the psychedelic compound found in magic mushrooms, helps to "open up" depressed people's brains, even after use, enabling brain regions to talk more freely to one another.
Apr 11, 2022
7
253
Cardamonin—a natural compound found in the spice cardamom and other plants—could have therapeutic potential for triple-negative breast cancer, according to a new study using human cancer cells. The findings also show ...
Apr 3, 2022
0
32
Researchers from the HSE Centre for Language and Brain worked with Russian doctors to address the differences between the symptoms of post-stroke aphasia and aphasia caused by glioma surgery. Post-surgery patients demonstrate ...
Apr 1, 2022
0
3
Exercise helps breast cancer patients with the physical and mental side effects of treatment, a new Loughborough University study has found, and ultimately it may improve disease prognosis.
Mar 25, 2022
0
149
Meningiomas, tumors of the membranes (meninges) surrounding the brain and spinal cord, are the most common tumors of the central nervous system. Although most meningiomas are low grade and cause few or no symptoms, a subset, ...
Mar 23, 2022
0
134
Research carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has demonstrated that mixing mitochondrial DNAs (mtDNAs) of different origins can have damaging effects over the medium and long term. ...
Mar 16, 2022
0
19
More effective therapies are needed for acute leukemia, particularly for people over 50 years of age at diagnosis, according to research published today by the Medical Journal of Australia.
Mar 14, 2022
0
2
One in five people who smoke also drink heavily, but they show worse outcomes than non-heavy drinkers in quitting smoking and are often excluded from smoking cessation trials. Knowing how challenging it can be to quit smoking, ...
Mar 4, 2022
0
33
Sanger researchers have created the world's largest novel resource using systematic drug testing and genetics analyses to show new potential drug combinations for breast, colon, and pancreatic cancer.
Feb 24, 2022
0
119
Investigators from UCLA Jonsson Comprehensive Cancer Center have identified a germline biomarker signature that successfully predicts which patients will suffer serious side effects that occur in up to 3 in ten patients on ...
Feb 3, 2022
0
29
